Scinai Immunotherapeutics logo

Scinai Immunotherapeutics share price today

(SCNI)

Scinai Immunotherapeutics share price is $3.44 & ₹293.33 as on 27 Dec 2024, 2.30 'hrs' IST

$3.44

0.09

(2.69%)

Market is closed - opens 8 PM, 27 Dec 2024

View live Scinai Immunotherapeutics share price in Dollar and Rupees. Guide to invest in Scinai Immunotherapeutics from India. Also see the sentimental analysis on Indian investors investing in Scinai Immunotherapeutics. Get details on the Indian mutual funds that are investing in Scinai Immunotherapeutics. Get Analyst recommendations and forecasts along with all the Scinai Immunotherapeutics's financials.

Scinai Immunotherapeutics share price movements

  • Today's Low: $3.35
    Today's High: $3.54

    Day's Volatility :5.37%

  • 52 Weeks Low: $2.23
    52 Weeks High: $8.92

    52 Weeks Volatility :75.0%

Scinai Immunotherapeutics Returns

PeriodScinai Immunotherapeutics LtdIndex (Russel 2000)
3 Months
-7.97%
0.0%
6 Months
20.5%
0.0%
1 Year
-52.14%
0.0%
3 Years
-74.81%
-21.1%

Scinai Immunotherapeutics Key Statistics

in dollars & INR

Previous Close
$3.35
Open
$3.3
Today's High
$3.54
Today's Low
$3.35
Market Capitalization
$2.9M
Today's Volume
$6.2K
52 Week High
$8.92
52 Week Low
$2.23
Revenue TTM
$284.0K
EBITDA
$-7.0M
Earnings Per Share (EPS)
$2.4
PE Ratio
1.4
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.26%
Return On Equity TTM
0.0%

How to invest in Scinai Immunotherapeutics from India?

It is very easy for Indian residents to invest directly in Scinai Immunotherapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Scinai Immunotherapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Scinai Immunotherapeutics or SCNI on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Scinai Immunotherapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Scinai Immunotherapeutics shares which would translate to 0.248 fractional shares of Scinai Immunotherapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Scinai Immunotherapeutics, in just a few clicks!

Returns in Scinai Immunotherapeutics for Indian investors in Rupees

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Scinai Immunotherapeutics investment value today

Current value as on today

₹51,468

Returns

₹48,532

(-48.53%)

Returns from Scinai Immunotherapeutics Stock

₹50,857 (-50.86%)

Dollar Returns

₹2,325 (+2.33%)

Indian investors sentiment towards Scinai Immunotherapeutics

50%

Period: Sep 27, 2024 to Dec 26, 2024. Change in 30 Days versus previous period

Search volume for Scinai Immunotherapeutics on INDmoney from India has grown in the last 30 days as on Dec 27, 2024. 50% more investors are searching Scinai Immunotherapeutics in the last 30 days versus the previous period.

Analyst Recommendation on Scinai Immunotherapeutics

Buy

    85%Buy

    14%Hold

    0%Sell

Based on 7 Wall street analysts offering stock ratings for Scinai Immunotherapeutics(by analysts ranked 0 to 5 stars)

Based on 7 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
6
6
6
Hold
1
1
1
Sell
0
0
0

Analyst Forecast on Scinai Immunotherapeutics

What analysts predicted

Upside of 20248.84%

Current:

$3.44

Target:

$700.00

Insights on Scinai Immunotherapeutics

  • Price Movement

    In the last 3 months, SCNI stock has moved down by -19.1%
  • SCNI vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 74.1%
  • Price to Sales

    ForSCNI every $1 of sales, investors are willing to pay $6.0, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Scinai Immunotherapeutics Technicals Summary

Sell

Neutral

Buy

Scinai Immunotherapeutics is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Scinai Immunotherapeutics Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Scinai Immunotherapeutics Ltd
-3.18%
20.5%
-52.14%
-74.81%
-74.81%
Regeneron Pharmaceuticals, Inc.
-5.12%
-32.02%
-18.97%
11.91%
91.19%
Biontech Se
-3.72%
42.02%
7.95%
-52.72%
226.93%
Alnylam Pharmaceuticals, Inc.
-3.99%
0.1%
24.29%
44.19%
112.09%
Vertex Pharmaceuticals Incorporated
-12.61%
-12.92%
-0.27%
83.92%
86.41%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Scinai Immunotherapeutics Ltd
1.4
1.4
NA
0.0
0.0
-0.28
NA
-9.84
Regeneron Pharmaceuticals, Inc.
17.67
17.67
1.06
45.07
0.17
0.07
NA
272.04
Biontech Se
160.8
NA
0.04
-3.11
-0.02
-0.01
NA
79.73
Alnylam Pharmaceuticals, Inc.
NA
NA
-0.49
-0.19
-15.01
-0.03
NA
0.25
Vertex Pharmaceuticals Incorporated
32.84
NA
1.06
0.51
-0.03
0.12
NA
60.65
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Scinai Immunotherapeutics Ltd
Buy
$2.9M
-74.81%
1.4
0.0%
Regeneron Pharmaceuticals, Inc.
Buy
$78.5B
91.19%
17.67
33.61%
Biontech Se
Buy
$27.4B
226.93%
160.8
-15.36%
Alnylam Pharmaceuticals, Inc.
Buy
$31.4B
112.09%
NA
-15.86%
Vertex Pharmaceuticals Incorporated
Buy
$105.1B
86.41%
32.84
-4.51%

About Scinai Immunotherapeutics

biondvax (nasdaq: bvxv) is an innovative biopharmaceutical company developing a universal flu vaccine, designed to provide multi-season and multi-strain protection against most human influenza virus strains, including both seasonal and pandemic flu strains. biondvax’s technology utilizes a unique, proprietary combination of conserved epitopes from influenza virus proteins to activate the immune system for a cross-protecting and long-lasting effect.
Organization
Scinai Immunotherapeutics
Employees
31
CEO
Mr. Amir Reichman M.B.A., M.Sc.
Industry
Miscellaneous

Management People of Scinai Immunotherapeutics

NameTitle
Mr. Amir Reichman M.B.A., M.Sc.
CEO & Director
Mr. Uri Ben-Or CPA, CPA, M.B.A., MBA
Chief Financial Officer
Mr. Elad Mark B.Sc., Eng., M.B.A.
Chief Operating Officer
Dr. Dalit Weinstein Fischer Ph.D.
Chief Technology Officer
Dr. Tamar Ben-Yedidia Ph.D.
Chief Scientist
Liat Halpert
Head of Business Development & Sales
Merav Kamensky
Head of Quality Control

Important FAQs about investing in Scinai Immunotherapeutics from India :

What is Scinai Immunotherapeutics share price today?

Scinai Immunotherapeutics share price today stands at $3.44, Open: $3.30 ; Previous Close: $3.35 ; High: $3.54 ; Low: $3.35 ; 52 Week High: $8.92 ; 52 Week Low: $2.23. The stock opens at $3.30, after a previous close of $3.35. The stock reached a daily high of $3.54 and a low of $3.35, with a 52-week high of $8.92 and a 52-week low of $2.23.

Can Indians buy Scinai Immunotherapeutics shares?

Yes, Indians can invest in the Scinai Immunotherapeutics (SCNI) from India.

With INDmoney, you can buy Scinai Immunotherapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Scinai Immunotherapeutics at zero transaction cost.

How can I buy Scinai Immunotherapeutics shares from India?

It is very easy to buy Scinai Immunotherapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Scinai Immunotherapeutics be purchased?

Yes, you can buy fractional shares of Scinai Immunotherapeutics with INDmoney app.

What are the documents required to start investing in Scinai Immunotherapeutics stocks?

To start investing in Scinai Immunotherapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Scinai Immunotherapeutics

Today’s highest price of Scinai Immunotherapeutics (SCNI) is $3.54.

Today’s lowest price of Scinai Immunotherapeutics (SCNI) is $3.35.

What is today's market capitalisation of Scinai Immunotherapeutics

Today's market capitalisation of Scinai Immunotherapeutics SCNI is 2.9M

What is the 52 Week High and Low Range of Scinai Immunotherapeutics

  • 52 Week High

    $8.92

  • 52 Week Low

    $2.23

What are the historical returns of Scinai Immunotherapeutics?

  • 1 Month Returns

    -3.18%

  • 3 Months Returns

    20.5%

  • 1 Year Returns

    -52.14%

  • 5 Years Returns

    -74.81%

Who is the Chief Executive Officer (CEO) of Scinai Immunotherapeutics

Mr. Amir Reichman M.B.A., M.Sc. is the current Chief Executive Officer (CEO) of Scinai Immunotherapeutics.